You are here: Home: OPU 1 | 2007: CME/CNE Information

Oncology Practice Update — A Continuing Education Audio Series

STATEMENT OF NEED/TARGET AUDIENCE

Breast cancer is one of the most rapidly evolving fields in oncology. Published results from ongoing clinical trials lead to the continuous emergence of new therapeutic agents with unique side-effect profiles and changes in the indications for existing treatments. To provide optimal patient care, the nurse practitioner, physician assistant and clinical nurse specialist must be well informed of treatment advances and the evidence-based rationale for current management strategies.

PURPOSE STATEMENT

The purpose of this activity is to provide nurse practitioners, physician assistants and clinical nurse specialists with information that helps them formulate up-to-date clinical management strategies for patients with breast cancer. To achieve this goal, Oncology Practice Update features the management perspectives of leading oncology investigators and practicing clinicians.

LEARNING OBJECTIVES

• Discuss the clinical implications of emerging clinical trial data in breast cancer, and apply this information to strategies in the adjuvant and metastatic settings.
• Evaluate the benefits and risks of endocrine therapy for the treatment of patients who are pre- and postmenopausal and have hormone receptor-positive breast cancer, and integrate this information into clinical practice.
• Describe the benefits and risks of various chemotherapeutic agents and regimens in the adjuvant and metastatic settings, and discuss this information with patients.
• Implement strategies, including supportive care measures and patient education, to minimize and manage toxicities secondary to systemic therapies.
• Determine the value of genetic assays and computerized risk models for predicting a patient’s risk of breast cancer recurrence and the benefit of adjuvant therapy.
• Explain the psychosocial and emotional needs of caregivers, patients and their loved ones, in the context of breast cancer diagnosis and treatment, and prepare management strategies that encompass care for the patient as a whole.

CREDIT DESIGNATION STATEMENTS
CNE INFORMATION

Nurses: This educational activity for 1.7 contact hours is provided by Research To Practice during the period of December 2007 through December 2008. Research To Practice is an approved provider of continuing nursing education by the New Jersey State Nurses Association, Provider Number P215-01/07-10. NJSNA is accredited by the ANCC Commission on Accreditation. Provider approval is valid through January 31, 2010.

Nurse Practitioners: This program has been approved for 1.7 contact hours of continuing education (which includes 0.5 hours of pharmacology) by the American Academy of Nurse Practitioners. Program ID 0710492. Participants may claim only the portion of the program that they successfully completed.

CME-PA INFORMATION

Physician Assistants: This program has been reviewed and is approved for a maximum of 1.75 hours of AAPA Category 1 CME credit by the Physician Assistant Review Panel. Approval is valid for one year from the issue date of December 10, 2007. Participants may submit the self assessment at any time during that period. This program was planned in accordance with AAPA’s CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.

HOW TO USE THIS ACTIVITY

This is an audio CNE/CME program. This website contains CNE/CME information, including learning objectives, faculty disclosures, a Post-test and an Evaluation Form, as well as links to relevant abstracts and full-text articles. To complete the program, participants should review the learning objectives and faculty disclosures, listen to the audio program and complete the Post-test and Evaluation Form.

Successful completion of the self assessment (Post-test) is required to earn CNE contact hours or Category 1 (Preapproved) CME credit. Successful completion is defined as a cumulative score of at least 70 percent correct on the Post-test. Your statement of credit will be mailed to you within three weeks or may be printed online.

This program is supported by educational grants from Abraxis BioScience, AstraZeneca Pharmaceuticals LP and Genomic Health Inc.